Sources

9 Total Sources

Merck, Gilead Halt Phase 3 Lung Cancer Trial After 620-Patient Study Misses PFS Goal

Center33%
Right33%
Far Right33%
Merck5h ago
Merck and Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Lung Cancer Study
t.co11h ago
Gilead and Merck pipeline update reveals promise in HIV and pressure in oncology - PharmaDeviceNews
StockTitan5h ago
Merck, Gilead halt Phase 3 KEYNOTE-D46 lung trial | MRK Stock News
BioSpace7h ago
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study - BioSpace
intellectia.ai5h ago
Merck and Gilead Discontinue Joint Study of Trodelvy and Keytruda | Intellectia.AI
Seeking Alpha5h ago
Merck, Gilead share positive phase 3 results from combination HIV pill | Seeking Alpha
Marketscreener.com5h ago
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study | MarketScreener
investors.gilead.com5h ago
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study - Gilead Sciences, Inc.
Stockhouse Publishing5h ago
2026-06-08 | Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study | NDAQ:GILD | Press Release